Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The British-Swedish pharmaceutical company AstraZeneca is expecting to move its Global Hub to the Estel building in Barcelona by the end of 2025, resulting in the creation of 830 new Jobs by the end of 2025.
For this purpose, the company plans to invest up to EUR 1.3 billion euro in this R&D centre until 2027 and create a team of 2,000 workers by the end of 2025. The AstraZeneca Global Hub, spanning 25,000 square metres, is dedicated to accelerating the development of a new generation of treatments across key therapeutic areas: oncology, rare diseases, cardiovascular, renal and metabolic conditions, respiratory and immunology, as well as vaccines and immunotherapies.
The company experienced an internal restructuring process in 2008, affecting 132 employees Astra Zeneca 2008-ES
Eurofound (2025), Astra Zeneca Spain, Business expansion in Spain, factsheet number 202434, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/202434.